The epidemiological impact of viral diseases, combined with the emergence and reemergence
of some viruses, and the difficulties in identifying effective therapies, have encouraged
several studies to develop new therapeutic strategies for viral infections. In this context, the use of immunotherapy
for the treatment of viral diseases is increasing. One of the strategies of immunotherapy
is the use of antibodies, particularly the monoclonal antibodies (mAbs) and multi-specific antibodies,
which bind directly to the viral antigen and bring about activation of the immune system. With current
advancements in science and technology, several such antibodies are being tested, and some are already
approved and are undergoing clinical trials. The present work aims to review the status of mAb
development for the treatment of viral diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.